Open

Peanut Allergy Immunotherapy Study

The purpose of this study is to learn more about the tolerability and safety of a daily immunotherapy tablet (SLIT-tablet) for people with peanut allergies. The goal of the SLIT-tablet is to increase tolerance to peanut protein, which could reduce the risk of allergic reactions caused by accidental exposure.

Age & Gender

4 years ~ 65 years
Male, Female

Visit Availability

Standard business hours (M-F, 8-5)

Location

North Carolina (Statewide)

What will be asked of you

If you decide to take part, you will contribute to the development of a peanut SLIT-tablet to benefit patients in the future. If you take part you will be offered the opportunity to take part in a future trial which includes at least 12 months of treatment with the peanut SLIT-tablet. Participation in this study involves lung function tests, completing an eDiary, Oral Food Challenges and blood draws.

Incentives

Telephone visits $20; In person visits $75-100, Parking Vouchers

In-person visits:
5-12

Phone or online visits:
4-8

Total length of participation:
1-6 months

Looking for Specific Volunteers

Able to participate:

You or your child has a peanut allergy
You have a history of IgE-mediated allergic reaction to peanut food

Not eligible if:

You have a diagnosis of eosinophilic esophagitis (EoE)
You have poorly controlled Asthma or Wheezing
You have a build-up of another immunotherapy
You have previously had peanut oral immunotherapy in last 12 months
You have a history of cardiovascular disease

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Edwin Kim
Pediatrics - Allergy Immunology and Rheumatology

Study Type

Clinical or Medical
Interventional

Study Topics

Chronic Conditions
Immune System/Infections

IRB Number

22-1338

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.